ClinicalTrials.gg
RecruitingNCT06335784Updated Mar 3, 2026

Mental Imagery and Targeted Memory Reactivation in Insomnia

An interventional study of Imagery Rescripting (IR) and Imagery Rescripting (IR) and Targeted Memory Reactivation (TMR) during sleep in Insomnia Disorder, sponsored by University Hospital, Geneva. Recruiting at 1 site in Switzerland. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-03-03.

Sponsored by University Hospital, Geneva · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2024; still recruiting 2 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 34 studies in Sleep Initiation and Maintenance Disorders with a site in Switzerland — 8 open to participants now, 9 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Switzerland.

Planned enrollment
10th of 27
120 · median 68
Started
2024
with 3 others
No phase
15 of 34
4 open now
Registered
25th of 34
by date
Lead sponsor
3 of 34
University Hospital, Geneva

Among the 34 studies in Sleep Initiation and Maintenance Disorders with a site in Switzerland, this one is the 10th largest by planned enrollment of the 27 interventional ones that give a count, is one of 4 that started in 2024, is one of 15 with no phase, and was the 25th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

8 of the 34 studies in Sleep Initiation and Maintenance Disorders with a site in Switzerland are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in Switzerland have not opened yet or have stopped. Only those recruiting at a site in Switzerland →

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years to 45 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Sleep Initiation and Maintenance Disorders with a site in Switzerland, or all of them as a file.
02

Study summary

In this clinical trial, the investigators test whether mental Imagery Rescripting (IR), a technique where the individual is instructed to transform a negative memory or image into a positive one, and olfactory Targeted Memory Reactivation (TMR), a technique used to strengthen memories, can reduce hyperarousal and insomnia severity in patients with Insomnia Disorder (ID).

Patients with ID will be randomized into four groups: in the first group (SH group), patients will have 4 weekly sessions (1 session/week) of a minimal intervention for insomnia (sleep hygiene information) in the presence of an odorless diffuser, which will be also used during the night. In the second group (IR group), patients will use IR during wakefulness to induce a state of relaxation and positive emotionality. More specifically, during 4 weekly sessions of IR, patients will imagine a negative scenario related to their pre-sleep images or current concerns (e.g., social interactions, self-image, sleep problem, nightmares) and transform it into a positive script. They will then perform IR every day for 4 weeks at home in the presence of an odorless diffuser, which will be also used during the night. In the third group, patients will undergo the same 4 weekly IR sessions and an odor will be paired to the positive imagery and will be diffused during the night (TMR group). Patients from this group will also perform IR every day for 4 weeks at home. Finally, the fourth group (OA group) will receive 4 weekly sessions of sleep hygiene instructions in the presence of an odor, which will be also used during the night.

Clinical evaluation of insomnia severity before and after the intervention will take place using the Insomnia Severity Index (ISI, primary outcome measure).

At the end of these interventions, patients with persistent symptoms will benefit from an alternative experimental treatment ("rocking bed") in which they will be cradled for one night.

The investigators hypothesize that patients treated with IR will have significantly reduced insomnia severity compared to participants who received a minimal intervention. They also hypothesize that patients of the TMR group, will have more reduced ID severity compared to participants performing IR and with an odorless diffuser, therefore without an association (IR group). Finally, they hypothesize that one night of sleeping in a rocking bed will improve objective measures of sleep in ID compared to a stationary condition.

03

Conditions studied

  • Insomnia Disorder

Keywords

  • Insomnia
  • Odors
  • Imagery
  • TMR
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 18 and 45 years
  • Insomnia disorder according to the International Classification of Diseases 3 (ICSD-3)
  • ISI > 10
  • PSQI > 5
  • No other current treatment for Insomnia

Exclusion criteria

Exclusion Criteria:

  • patients with another psychiatric disorder requiring acute treatment according to
  • patients with medical (e.g. neurological disorders) or other disorders explaining the predominant complaint of insomnia (e.g., sleep apneas with ODI>15/h, restless legs syndrome, periodic limb movements with PLM>15, chronic pain)
  • patients with significant substance use/withdrawal
  • patients with heavy smoking
  • known pregnancy
  • patients suffering from anosmia, olfactory related issues and respiratory pathology
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Sleep Hygiene (SH)

    Participants will receive 4 weekly individual sessions of standardized instructions on sleep hygiene, that they will be asked to apply every day for 4 weeks. Each session will consist of providing patients with advice to help their sleep without any CBT-I or other complementary medicine components. They will also have an odorless diffuser being diffused at the end of each weekly individual session and during the night.

    Behavioral: Sleep Hygiene · Other: "Rocking bed" if patients still have insomnia complaints (ISI >10) after the 4 weeks of the intervention

  • Experimental
    Imagery Rescripting (IR)

    Participants will receive 4 weekly individual sessions of IR. The IR technique consists of imagining a negative memory or image as vividly as possible, and of transforming it into a positive one. An odorless diffuser will be presented while imagining the positive imagery generated during IR. During 4 weeks, patients of this group will practice IR at home, every day in bed and have the same odorless diffuser being diffused during the night.

    Behavioral: Imagery Rescripting (IR) · Other: "Rocking bed" if patients still have insomnia complaints (ISI >10) after the 4 weeks of the intervention

  • Experimental
    Targeted Memory Reactivation (TMR)

    Participants will receive 4 weekly individual sessions of IR, at the end of which, a chosen odor will be presented while imagining the positive imagery generated during IR. During 4 weeks, patients of this group will practice IR at home every day in bed and have the same odor being diffused during the night.

    Behavioral: Imagery Rescripting (IR) and Targeted Memory Reactivation (TMR) during sleep · Other: "Rocking bed" if patients still have insomnia complaints (ISI >10) after the 4 weeks of the intervention

  • Active comparator
    Odor Alone (OA)

    Participants will have a chosen odor diffused during the night for 4 weeks and will receive 4 weekly individual sessions of standardized instructions on sleep hygiene, that they will be asked to apply every day for 4 weeks. The chosen odor will be diffused at the end of each weekly individual session.

    Behavioral: Sleep Hygiene + Odor · Other: "Rocking bed" if patients still have insomnia complaints (ISI >10) after the 4 weeks of the intervention

Interventions

  • BehavioralImagery Rescripting (IR)

    Imagery rescripting (IR) is a technique where the individual is instructed to imagine a negative memory or image as vividly as possible, and to change it in a direction that he/she desires. IR seems particularly efficient because it is based on the experienced emotions during perceptual information processing, thereby eliciting stronger emotional responses than verbal processing.

  • BehavioralImagery Rescripting (IR) and Targeted Memory Reactivation (TMR) during sleep

    Targeted Memory Reactivation (TMR) is a technique used to strengthen a memory trace during sleep. TMR is used to modify memory formation through the application of cues during sleep. In this TMR protocol, an olfactory cue is associated with the imagery rescripting (IR) during the day, and then administered during sleep. In that way, the replay of the associated memory and its corresponding neural representation in memory networks are artificially promoted, a procedure which usually strengthens memory consolidation. Previous studies have shown that TMR in sleep reduces emotional arousal, making it a promising technique for insomnia.

  • BehavioralSleep Hygiene

    Sleep hygiene education includes modifications in the behavior (e.g., exercise, coffee, alcohol intake) and environment (e.g., light, noise, temperature conditions) that offer to the individual the foundation for healthy sleep. Sleep hygiene is an important component in treating ID, but insufficient and less effective than CBT-I when offered alone.

  • BehavioralSleep Hygiene + Odor

    Sleep hygiene instructions will be applied in the presence of an odor, which will be also used during the night.

  • Other"Rocking bed" if patients still have insomnia complaints (ISI >10) after the 4 weeks of the intervention

    Rocking stimulation boosts brain oscillations in deep sleep (i.e., sleep spindles and slow oscillations) into a rhythmic appearance supporting a neurophysiological mechanism whereby continuous rocking entrains endogenous thalamo-cortical sleep oscillations. The beneficial effects of rocking strengthening the continuity of sleep might have clinical applications and it will be of interest to evaluate if such non-pharmacological could improve sleep and reduce such features of hyperarousal in ID patients.

06

What researchers measure

Primary outcomes

  1. Insomnia Severity Index (ISI)

    Standardized questionnaire that measures ID severity, the score ranges from 0-28, zero indicating no symptom severity and 28 indicating the higher symptom severity.

    Time frame: Baseline, 5 Weeks and 3 Months

Secondary outcomes

  1. Pittsburgh sleep quality index (PSQI)

    Validated self-report scale to assess the quality of sleep, the score ranges from 0-21, zero indicating no symptom severity and 21 indicating the higher symptom severity.

    Time frame: Baseline, 5 Weeks and 3 Months

  2. Total Sleep Time (TST)

    Time from sleep onset to sleep offset. This outcome is measured both subjectively and objectively.

    Time frame: Baseline and 5 Weeks

  3. Wake After Sleep Onset (WASO)

    Number of awakenings during the night. This outcome is measured both subjectively and objectively.

    Time frame: Baseline and 5 Weeks

  4. Beck Depression Inventory II (BDI-II)

    Validated self-report scale to assess depressive symptoms, the score ranges from 0-63, zero indicating no symptom severity and 63 indicating the higher symptom severity.

    Time frame: Baseline, 5 Weeks and 3 Months

  5. State Trait Anxiety Inventory (STAI)

    Validated self-report scale to assess anxiety, the score ranges from 20-80, 20 indicating no symptom severity and 80 indicating the higher symptom severity.

    Time frame: Baseline, 5 Weeks and 3 Months

  6. Sleep efficiency (SE)

    Ratio between total time spent in bed and total sleep time. This outcome is measured both subjectively and objectively.

    Time frame: Baseline and 5 Weeks

  7. Micro-arousals

    Objective measure of micro-awakenings during the night.

    Time frame: Baseline and 5 Weeks

Other outcomes

  1. Temperament and Character Inventory

    A 240-item self-administered questionnaire designed to measure 4 temperament and 3 character scales.

    Time frame: Baseline and 5 Weeks

  2. Pre-sleep Arousal Scale (PSAS)

    A 16-item self-reported questionnaire designed to measure pre-sleep arousability, the score ranges from 16-80, 16 indicating no symptom severity and 80 indicating the higher symptom severity.

    Time frame: Baseline and 5 Weeks

  3. Arousal Predisposition Scale (APS)

    A 12-item self-reported questionnaire designed to measure arousability

    Time frame: Baseline and 5 Weeks

  4. Digit Span Task

    A working memory task, asking the participant to repeat a string of numbers which are displayed verbally, exactly as given, for "digits forward," and in reverse order for "digits backward"

    Time frame: Baseline and 5 Weeks

  5. Psychomotor Vigilance Task (PVT)

    A sustained-attention, reaction-timed task that measures the speed with which subjects respond to a visual stimulus.

    Time frame: Baseline and 5 Weeks

  6. Declarative word paired-associate learning task

    Subjects will be instructed to learn 46 word-pairs with an immediate (pre-sleep) and a delayed one (post-sleep) to assess overnight improvement

    Time frame: Baseline and 5 Weeks

  7. Attachment Style Questionnaire (ASQ)

    A 40-item self-reported questionnaire designed to measure attachment style.

    Time frame: Baseline and 5 Weeks

07

Study locations

1 of 1 sites recruiting
  • Center for Sleep Medicine
    Geneva, Switzerland
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2024 (actual). Primary completion is estimated for May 2027, 37 months after the start.

Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 37 months is above that.

Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 21, 2024
First posted
Mar 28, 2024
StartActual
Apr 22, 2024
Primary completionEst.
May 31, 2027
CompletionEst.
Aug 31, 2027
Last update
Mar 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06335784
Collaborators
University of Geneva, Switzerland
Responsible party
Lampros Perogamvros (Attending Physician, University Hospital, Geneva) — Principal investigator
First posted
Mar 28, 2024
Start date
Apr 22, 2024
Primary completion
May 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Mar 3, 2026

Study contacts

Lampros Perogamvros
Contact
Lampros.Perogamvros@hcuge.ch
+41223729946
Kevin Mammeri
Contact
Kevin.Mammeri@unige.ch
+33627694534

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion